Key result
Transcatheter aortic valve implantation (TAVI) in older adults resulted in significant symptom improvement but no significant change in mean activities of daily living (NEADL mean difference 0.3, p=0.7) at 6 months.
Why the study?
To examine baseline frailty status, including cognitive deficits, and important clinical outcomes to inform shared decision-making in older adults receiving TAVI.
Does transcatheter aortic valve implantation (TAVI) improve symptoms and activities of daily living in older adults with severe aortic stenosis?
Cohort (n=82)
No
Does transcatheter aortic valve implantation (TAVI) improve symptoms and activities of daily living in older adults with severe aortic stenosis?
Mean Difference: 0.3
Absolute Event Rate: 54.5% vs 54.2%
p-value: p=0.7
TAVI in older adults with severe aortic stenosis significantly improved heart failure symptoms and maintained activities of daily living at 6 months, with low 2-year mortality but a 7% incidence of infective endocarditis.
Supports symptom relief without ADL gains after TAVI in older adults; leaves open need for RCTs on functional outcomes.
AIMS: The objective of this study was to examine baseline frailty status (including cognitive deficits) and important clinical outcomes, to inform shared decision-making in older adults receiving transcatheter aortic valve implantation (TAVI). METHODS AND RESULTS: We conducted a prospective, observational study of 82 TAVI patients, recruited 2013 to 2015, with 2-year follow-up. Mean age was 83 years (standard deviation (SD) 4.7). Eighteen percent of the patients were frail, as assessed with an 8-item frailty scale. Fifteen patients (18%) had a Mini-Mental Status Examination (MMSE) score below 24 points at baseline, indicating cognitive impairment or dementia and five patients had an MMSE below 20 points. Mean New York Heart Association (NYHA) class at baseline and 6 months was 2.5 (SD 0.6) and 1.4 (SD 0.6), (p < 0.001). There was no change in mean Nottingham Extended Activities of Daily Living (NEADL) scale between baseline and 6 months, 54.2 (SD 11.5) and 54.5 (SD 10.3) points, respectively, mean difference 0.3 (p = 0.7). At 2 years, six patients (7%) had died, four (5%, n = 79) lived in a nursing home, four (5%) suffered from disabling stroke, and six (7%) contracted infective endocarditis. CONCLUSIONS: TAVI patients had improvement in symptoms and maintenance of activity of daily living at 6 months. They had low mortality and most patients lived in their own home 2 years after TAVI. Complications like death, stroke, and endocarditis occurred. Some patients had cognitive impairment before the procedure which might influence decision-making. Our findings may be used to develop pre-TAVI decision aids.
No takes yet. Share an insight, caveat, or question.
Skaar et al. (2020) conducted a cohort in Severe and symptomatic aortic stenosis (n=82). Transcatheter aortic valve implantation (TAVI) vs. Baseline (pre-intervention) was evaluated on Nottingham Extended Activities of Daily Living (NEADL) scale at 6 months (mean difference 0.3, p=0.7). Transcatheter aortic valve implantation (TAVI) in older adults resulted in significant symptom improvement but no significant change in mean activities of daily living (NEADL mean difference 0.3, p=0.7) at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: